We are not sure of the reason, but it seems that every three months or so, a national media outlet weighs in on an old story: tainted nutritional supplements. The latest is a rehash of anecdotes with the same question: Are vitamins safe? So goes the Sept. 7 article in the Wall Street Journal headlined, “What’s Really in Supplements?”
Nutraceutical Corp. has filed a motion for rehearing and for rehearing en banc of the decision of the United States Court of Appeals for the Tenth Circuit in Neutraceutical Corp. v. Von Eschenbach, No. 05-4151 (Aug. 17, 2006). The Tenth Circuit’s decision reversed the Utah District Court and held that the FDA’s ban on low [...]
In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA’s ban on low dose ephedra was not arbitrary or capricious. Next stop, Supreme Court? Neutraceutical Corp. v. Von Eschenbach, No. 05-4151 (Aug. 17, 2006)
The wisdom of the FDA ban on ephedra has again been called into question, this time by a double-blind placebo controlled study published in the International Journal of Obesity. The study is entitled “Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.” The [...]
MII Liquidation Inc., as the former Metabolife International Inc. is now known, said in a court document filed Wednesday that it had reached agreements to settle the first 21 of hundreds of injury and death lawsuits over its once best-selling ephedra-based dietary supplement. About $4.7 million of the San Diego-based company’s insurance coverage would pay [...]
FDA announced more ephedra seizures last Friday, this time from Hi-Tech Pharmaceuticals, an Atlanta area supplement maker. For the FDA press release, click here. We previously mentioned Hi-Tech in connection with a trade dress dispute here. This time, FDA has gone after what it describes as $3M in product marketed under the brand names “Lipodrene,” [...]
